These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modern Vaccines/Adjuvants Formulation Session 6: Vaccine &Adjuvant Formulation & Production 15-17 May 2013, Lausanne, Switzerland. Fox CB Hum Vaccin Immunother; 2013 Sep; 9(9):2007-8. PubMed ID: 23787558 [TBL] [Abstract][Full Text] [Related]
6. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt. Tunheim G; Naess LM; Acevedo R; Fjeldheim ÅK; Bolstad K; García L; Cardoso D; Aase A; Zayas C; González H; Rosenqvist E; Norheim G Vaccine; 2014 Nov; 32(49):6631-8. PubMed ID: 25305564 [TBL] [Abstract][Full Text] [Related]
7. Aluminum adjuvant dose guidelines in vaccine formulation for preclinical evaluations. Vecchi S; Bufali S; Skibinski DA; O'Hagan DT; Singh M J Pharm Sci; 2012 Jan; 101(1):17-20. PubMed ID: 21918987 [TBL] [Abstract][Full Text] [Related]
8. Effects of stabilizers on the destabilization of proteins upon adsorption to aluminum salt adjuvants. Peek LJ; Martin TT; Elk Nation C; Pegram SA; Middaugh CR J Pharm Sci; 2007 Mar; 96(3):547-57. PubMed ID: 17080408 [TBL] [Abstract][Full Text] [Related]
9. A rational, systematic approach for the development of vaccine formulations. Morefield GL AAPS J; 2011 Jun; 13(2):191-200. PubMed ID: 21347616 [TBL] [Abstract][Full Text] [Related]
16. [Anti-meningococcal vaccines]. Taha MK; Alonso JM Rev Prat; 2008 Dec; 58(19):2099-101. PubMed ID: 19213536 [TBL] [Abstract][Full Text] [Related]
17. Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability. Clapp T; Siebert P; Chen D; Jones Braun L J Pharm Sci; 2011 Feb; 100(2):388-401. PubMed ID: 20740674 [TBL] [Abstract][Full Text] [Related]
18. Preformulation Characterization, Stabilization, and Formulation Design for the Acrylodan-Labeled Glucose-Binding Protein SM4-AC. Sahni N; Chaudhuri R; Hickey JM; Manikwar P; D'Souza A; Metters A; Joshi SB; Middaugh CR; Volkin DB J Pharm Sci; 2017 May; 106(5):1197-1210. PubMed ID: 28088457 [TBL] [Abstract][Full Text] [Related]
19. New vaccines require potent adjuvants like AFPL1 and AFCo1. Pérez O; Lastre M; Cabrera O; del Campo J; Bracho G; Cuello M; Balboa J; Acevedo R; Zayas C; Gil D; Mora N; González D; Pérez R; González E; Barberá R; Fajardo EM; Sierra G; Solís RL; Campa C Scand J Immunol; 2007; 66(2-3):271-7. PubMed ID: 17635804 [TBL] [Abstract][Full Text] [Related]
20. Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method. Chen D; Kapre S; Goel A; Suresh K; Beri S; Hickling J; Jensen J; Lal M; Preaud JM; Laforce M; Kristensen D Vaccine; 2010 Jul; 28(31):5093-9. PubMed ID: 20478345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]